← back to search

Yuan Jiang

Capital Medical University · CN
Area of research
Cancer Research · Epidemiology
Research interest
Research interests include Cancer, Hypoxia, and Metabolism, Cancer-related molecular mechanisms research, Autophagy in Disease and Therapy, and Immune Cell Function and Interaction.
h-index
10
citations
436
works
26
NIH funding
primary concept
email

Recent publications

MicroRNA-15b promotes cardiac ischemia injury by the inhibition of Mitofusin 2/PERK pathway
Biochemical Pharmacology 2024cited by 3position: middledoi
Cullin-associated and neddylation-dissociated protein 1 (CAND1) alleviates NAFLD by reducing ubiquitinated degradation of ACAA2
Nature Communications 2023cited by 30position: middledoi
Interdependent Nuclear Co-Trafficking of ASPP1 and p53 Aggravates Cardiac Ischemia/Reperfusion Injury
Circulation Research 2022cited by 45position: middledoi
Fibroblast growth factor-23 and the risk of cardiovascular diseases and mortality in the general population: A systematic review and dose-response meta-analysis
Frontiers in Cardiovascular Medicine 2022cited by 22position: middledoi
Cytoplasmic sequestration of p53 by lncRNA-CIRPILalleviates myocardial ischemia/reperfusion injury
Communications Biology 2022cited by 12position: firstdoi
The long noncoding RNA lncCIRBIL disrupts the nuclear translocation of Bclaf1 alleviating cardiac ischemia–reperfusion injury
Nature Communications 2021cited by 63position: middledoi
IL-6 and IL-8 are likely associated with psychological status in treatment naïve general population
Journal of Affective Disorders 2021cited by 17position: middledoi
Increase of late sodium current contributes to enhanced susceptibility to atrial fibrillation in diabetic mice
European Journal of Pharmacology 2019cited by 32position: middledoi
Ablation of interleukin-17 alleviated cardiac interstitial fibrosis and improved cardiac function via inhibiting long non-coding RNA-AK081284 in diabetic mice
Journal of Molecular and Cellular Cardiology 2018cited by 90position: middledoi
miR-106a promotes cardiac hypertrophy by targeting mitofusin 2
Journal of Molecular and Cellular Cardiology 2016cited by 73position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Baofeng Yang · Shenyang Pharmaceutical University6 papers (2016–2023)Yanjie Lu · Ministry of Education of the People's Republic of China5 papers (2018–2023)Ying Yang · Harbin Medical University5 papers (2018–2023)Genlong Xue · Harbin Medical University5 papers (2018–2022)Xiaofang Zhang · University of Science and Technology Liaoning5 papers (2018–2023)Zhenwei Pan · Indiana University School of Medicine5 papers (2019–2023)Xingda Li · Harbin Medical University3 papers (2022–2023)Xuexin Jin · Harbin Medical University3 papers (2018–2021)Ji-Qin Yang · Harbin Medical University3 papers (2021–2022)Shang‐Xuan Li · The First Affiliated Hospital, Sun Yat-sen University3 papers (2021–2023)Haiyu Gao · Harbin Medical University2 papers (2021–2023)Qihe Huang · Harbin Medical University2 papers (2019–2022)Jianyong Ma · Nanchang University2 papers (2021–2022)Hongli Shan · Ministry of Education of the People's Republic of China2 papers (2022–2022)Jiahui Song · Harbin Medical University2 papers (2022–2023)Lina Xuan · Harbin Medical University2 papers (2022–2023)Yang Zhang · Xinjiang Medical University2 papers (2022–2023)Tao Tian · Chinese Academy of Medical Sciences & Peking Union Medical College2 papers (2021–2022)Lexin Zhao · Harbin Medical University2 papers (2022–2023)Zhiwen Zhou · Fudan University2 papers (2022–2023)